<DOC>
	<DOCNO>NCT01286909</DOCNO>
	<brief_summary>A trial LaFlavon Patients Metabolic Syndrome Evaluate Effectiveness Lowering Triglycerides Raising High-Density Lipoprotein ( HDL ) .</brief_summary>
	<brief_title>Efficacy Laflavon Lowering Triglycerides Raising High-Density Lipoprotein ( HDL )</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Lycopene</mesh_term>
	<criteria>1 . Men Women Metabolic Syndrome 2 . Elevated Triglycerides ( &gt; 150 ) 3 . Low HighDensity Lipoprotein ( HDL ) ( &lt; 35 ) 4 . Willingness take study nutritional supplement day 3 month 1 . Women pregnant , nursing , intend pregnancy period treatment 2 . Known milk , soy whey allergy</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Metabolic</keyword>
</DOC>